{"id":"W4376286734","doi":"10.1016/j.eururo.2023.04.031","title":"Re: Darolutamide plus Androgen-deprivation Therapy and Docetaxel in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hazard ratio; Prostate cancer; Docetaxel; Prednisone; Abiraterone acetate; Internal medicine; Oncology; Proportional hazards model; Confidence interval; Androgen deprivation therapy; Enzalutamide; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001171932,0.0004131376,0.0007095246,0.0003670349,0.0001193184,0.00006153934,0.0001398972,0.0001388499,0.0000164681],"category_scores_gemma":[0.0002066289,0.0002792538,0.00007964528,0.0003774529,0.0004345234,0.00008134931,0.00009736664,0.001659694,0.0000200269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001296642,"about_ca_system_score_gemma":0.0002088268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005970213,"about_ca_topic_score_gemma":0.0001558899,"domain_scores_codex":[0.9956071,0.002073681,0.0005106081,0.0008089728,0.0003716287,0.0006280129],"domain_scores_gemma":[0.9986808,0.0004672734,0.0002470748,0.0004083065,0.00006037778,0.0001361973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2513721,0.0007100971,0.01547841,0.0002537325,0.001212374,0.05214132,0.01252393,0.00003076056,0.0004517589,0.000004204675,0.6455844,0.02023688],"study_design_scores_gemma":[0.4902653,0.00818101,0.09715789,0.0001741496,0.001512279,0.0001429775,0.0007693256,0.002604888,0.00004359252,0.0002548512,0.3977749,0.001118865],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8129657,0.01164572,0.000005947501,0.1713874,0.0001379451,0.002902295,0.0008154917,0.00004333982,0.0000961798],"genre_scores_gemma":[0.7989315,0.0897151,0.00001682394,0.1033842,0.001411906,0.0005457451,0.003315836,0.0002403316,0.002438513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2478095,"threshold_uncertainty_score":0.999966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03953950541478287,"score_gpt":0.3162875686684111,"score_spread":0.2767480632536283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}